MAPS Launches ‘Music is the Bridge’ Campaign Featuring Lil Yachty, Melissa Etheridge, Reggie Watts and More
December 09, 2024 09:00 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS’ “Music is the Bridge” blends artist playlists & free psychedelic education, inspiring exploration and connection. Visit MAPS.org/music-is-the-bridge
Psychedelic Science 2025 Conference Announces Workshops, Holiday Sale, and Scholarship Deadline
December 05, 2024 15:44 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
World’s leading psychedelic conference kicks off with workshops from leaders in science, medicine, therapy, policy, Indigenous medicine, and societyUpcoming deadline: speaker submissions, initial...
MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute
November 20, 2024 12:40 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
After three years of negotiation with the FDA, MAPS has successfully secured FDA clearance to conduct a clinical trial, MJP2, to examine the use of smoked cannabis for the treatment of PTSD symptoms...
MAPS Awards Grant for Pilot MDMA-assisted Massed Exposure Therapy Trial
August 27, 2024 07:00 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS, which has incubated and funded cutting-edge psychedelic research for decades, is continuing to advance our understanding of psychedelic-assisted therapiesThis study is one of the first trials...
MAPS Statement on FDA Complete Response Letter for MDMA-Assisted Therapy for PTSD New Drug Application
August 09, 2024 21:33 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS remains confident in its goal of making access to MDMA-assisted therapy for PTSD safe and legal SAN JOSE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for...
Three Pivotal Drug Policy Organizations Hold Media Briefing/Q&A on DEA Rescheduling of Cannabis
May 01, 2024 17:54 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- What: The Multidisciplinary Association for Psychedelic Studies (MAPS), The Marijuana Policy Project (MPP), and the National Organization for the...
MAPS Provides Psychedelic Crisis Assessment and Intervention Training to Denver’s First Responders
March 11, 2024 11:50 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS uses its over 30 years of experience in the psychedelic space to offer a first-of-its-kind gold-standard training program.
MAPS Announces Celestial Plans for Its 38th Anniversary
March 07, 2024 12:34 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
MAPS, which celebrates its 38th anniversary on April 8, will celebrate with a total solar eclipse at the Texas Eclipse 2024 festival in Texas
Psychedelic Science 2025 – the Fifth and Largest Psychedelic Conference in History – Announced for June 16-20 2025 in Denver, Colorado
February 13, 2024 13:29 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
SAN JOSE, Calif. , Feb. 13, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) has announced that the Psychedelic Science 2025 Conference will convene in the...
MAPS Congratulates Lykos Therapeutics on Acceptance of New Drug Application for MDMA-Assisted Therapy for PTSD
February 09, 2024 19:30 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
The FDA has accepted Lykos Therapeutics' New Drug Application, supported by two decades of research incubated by MAPS, for MDMA-assisted therapy for PTSD.